Actively Recruiting
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-28
1000
Participants Needed
4
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.
CONDITIONS
Official Title
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older with a history of primary invasive cancer under surveillance at Memorial Sloan Kettering Cancer Center (MSK)
- Completion of an exercise survey at baseline as part of MSK Cancer Survivorship Program
- Completion of a historical exercise survey 9-15 months prior reporting non-exercising status (less than 10 MET-hours per week)
- No evidence of recurrent or metastatic disease in the 15 months before baseline exercise assessment
- Completion of all definitive primary adjuvant therapy at least 3 months before the historical exercise survey; adjuvant hormonal therapy allowed anytime
- Undergoing surveillance in the MSK Cancer Survivorship Program
- Adult cancer survivors under surveillance at MSK between 2011 and 2023
- Self-reported non-exercising status (less than 5 MET-hours per week) 9-15 months before baseline assessment
- Documented history of absolute contraindications to moderate-intensity exercise assessed by specific medical conditions (congestive heart failure, valvular disease, chronic pulmonary disease, or renal failure)
- No evidence of recurrent or metastatic disease by radiological or pathological records in the 15 months before baseline
- Completion of all definitive primary adjuvant therapy at least 3 months before the historical exercise survey; adjuvant endocrine therapy permitted
You will not qualify if you...
- Patients who completed an additional exercise survey between the historical survey and baseline
- Evidence of recurrent or metastatic disease in the 15 months before baseline exercise assessment
- Presence of absolute contraindications to moderate-intensity exercise such as congestive heart failure, valvular disease, chronic pulmonary disease, or renal failure before baseline exercise assessment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
City of Hope Cancer Center (Data Analysis Only)
Duarte, California, United States, 91010
Not Yet Recruiting
2
University of California, Los Angeles (Data or Specimen Analysis Only)
Los Angeles, California, United States, 90095-1781
Not Yet Recruiting
3
Weill Cornell Medical College (Data or Specimen Analysis Only)
New York, New York, United States, 10021
Not Yet Recruiting
4
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065
Actively Recruiting
Research Team
J
Jessica Scott, PhD
CONTACT
C
Chaya Moskowitz, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here